标题
Understanding the Impact of Resistance to Influenza Antivirals
作者
关键词
-
出版物
CLINICAL MICROBIOLOGY REVIEWS
Volume 34, Issue 2, Pages -
出版商
American Society for Microbiology
发表日期
2021-02-02
DOI
10.1128/cmr.00224-20
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017–2018
- (2020) Emi Takashita et al. ANTIVIRAL RESEARCH
- Favipiravir and Zanamivir Cleared Infection with Influenza B in a Severely Immunocompromised Child
- (2020) Casper K Lumby et al. CLINICAL INFECTIOUS DISEASES
- We shouldn’t worry when a virus mutates during disease outbreaks
- (2020) Nathan D. Grubaugh et al. Nature Microbiology
- Baloxavir Marboxil 2% Granules in Japanese Children With Influenza
- (2020) Takato Yokoyama et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial
- (2020) Michael G Ison et al. LANCET INFECTIOUS DISEASES
- Baloxavir Marboxil for Prophylaxis against Influenza in Household Contacts
- (2020) Hideyuki Ikematsu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Baloxavir Marboxil Single-dose Treatment in Influenza-infected Children
- (2020) Jeffrey Baker et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Burden of influenza B virus infection and considerations for clinical management
- (2020) Hassan Zaraket et al. ANTIVIRAL RESEARCH
- In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2017–18 season: Comparison with the 2010–11 to 2016–17 seasons
- (2019) Hideyuki Ikematsu et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Treatment-Emergent Influenza Variant Viruses With Reduced Baloxavir Susceptibility: Impact on Clinical and Virologic Outcomes in Uncomplicated Influenza
- (2019) Takeki Uehara et al. JOURNAL OF INFECTIOUS DISEASES
- Baloxavir marboxil in Japanese pediatric patients with influenza: safety and clinical and virologic outcomes
- (2019) Nobuo Hirotsu et al. CLINICAL INFECTIOUS DISEASES
- The Ecology and Evolution of Influenza Viruses
- (2019) Michelle Wille et al. Cold Spring Harbor Perspectives in Medicine
- Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the Influenza Resistance Information Study
- (2018) Bruno Lina et al. Influenza and Other Respiratory Viruses
- Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
- (2018) A Danielle Iuliano et al. LANCET
- Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil
- (2018) Shinya Omoto et al. Scientific Reports
- Genetic bottlenecks in intraspecies virus transmission
- (2018) John T McCrone et al. Current Opinion in Virology
- Comparison of antiviral resistance across acute and chronic viral infections
- (2018) Stephen Mason et al. ANTIVIRAL RESEARCH
- Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents
- (2018) Frederick G. Hayden et al. NEW ENGLAND JOURNAL OF MEDICINE
- The mechanism of resistance to favipiravir in influenza
- (2018) Daniel H. Goldhill et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effectiveness of influenza vaccination on influenza-associated hospitalisations over time among children in Hong Kong: a test-negative case-control study
- (2018) Shuo Feng et al. Lancet Respiratory Medicine
- Antibiotic resistance: a rundown of a global crisis
- (2018) Bilal Aslam et al. Infection and Drug Resistance
- Evolution of Influenza A Virus by Mutation and Re-Assortment
- (2017) Wenhan Shao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Antibiotic therapy in neonates and impact on gut microbiota and antibiotic resistance development: a systematic review
- (2017) Jon Widding Fjalstad et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Slow but Steady Wins the Race: Dissimilarities among New Dual Inhibitors of the Wild-Type and the V27A Mutant M2 Channels of Influenza A Virus
- (2017) Marta Barniol-Xicota et al. JOURNAL OF MEDICINAL CHEMISTRY
- Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
- (2017) Yousuke FURUTA et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Narrowing the spectrum: the new frontier of precision antimicrobials
- (2017) Alexandra E. Paharik et al. Genome Medicine
- Drug resistance in influenza A virus: the epidemiology and management
- (2017) Mazhar Hussain et al. Infection and Drug Resistance
- Barriers of Influenza Vaccination Intention and Behavior – A Systematic Review of Influenza Vaccine Hesitancy, 2005 – 2016
- (2017) Philipp Schmid et al. PLoS One
- Approved Antiviral Drugs over the Past 50 Years
- (2016) Erik De Clercq et al. CLINICAL MICROBIOLOGY REVIEWS
- Crystal structure of the drug-resistant S31N influenza M2 proton channel
- (2016) Jessica L. Thomaston et al. PROTEIN SCIENCE
- Antibiotic-Induced Changes in the Intestinal Microbiota and Disease
- (2016) Simone Becattini et al. TRENDS IN MOLECULAR MEDICINE
- Characterization of a Large Cluster of Influenza A(H1N1)pdm09 Viruses Cross-Resistant to Oseltamivir and Peramivir during the 2013-2014 Influenza Season in Japan
- (2015) Emi Takashita et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New polycyclic dual inhibitors of the wild type and the V27A mutant M2 channel of the influenza A virus with unexpected binding mode
- (2015) Matias Rey-Carrizo et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Intrahost Dynamics of Antiviral Resistance in Influenza A Virus Reflect Complex Patterns of Segment Linkage, Reassortment, and Natural Selection
- (2015) Matthew B. Rogers et al. mBio
- Adamantane-Resistant Influenza A Viruses in the World (1902–2013): Frequency and Distribution of M2 Gene Mutations
- (2015) Guoying Dong et al. PLoS One
- Antibiotic Exposure and Other Risk Factors for Antimicrobial Resistance in Nasal Commensal Staphylococcus aureus: An Ecological Study in 8 European Countries
- (2015) Evelien M. E. van Bijnen et al. PLoS One
- Laninamivir octanoate for post-exposure prophylaxis of influenza in household contacts: a randomized double blind placebo controlled trial
- (2013) Seizaburo Kashiwagi et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Discovery of Novel Dual Inhibitors of the Wild-Type and the Most Prevalent Drug-Resistant Mutant, S31N, of the M2 Proton Channel from Influenza A Virus
- (2013) Jizhou Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Characteristics of a Widespread Community Cluster of H275Y Oseltamivir-Resistant A(H1N1)pdm09 Influenza in Australia
- (2012) A. C. Hurt et al. JOURNAL OF INFECTIOUS DISEASES
- Presence of Oseltamivir-Resistant Pandemic A/H1N1 Minor Variants Before Drug Therapy With Subsequent Selection and Transmission
- (2012) Elodie Ghedin et al. JOURNAL OF INFECTIOUS DISEASES
- The Ongoing Battle Against Influenza: Drug-resistant influenza viruses: why fitness matters
- (2012) Anne Kelso et al. NATURE MEDICINE
- Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives
- (2011) Aeron C Hurt et al. LANCET INFECTIOUS DISEASES
- Efficacy and Safety of Intravenous Peramivir for Treatment of Seasonal Influenza Virus Infection
- (2010) S. Kohno et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Long-Acting Neuraminidase Inhibitor Laninamivir Octanoate (CS-8958) versus Oseltamivir as Treatment for Children with Influenza Virus Infection
- (2010) N. Sugaya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Influenza Virus Evolution, Host Adaptation, and Pandemic Formation
- (2010) Jeffery K. Taubenberger et al. Cell Host & Microbe
- Long‐Acting Neuraminidase Inhibitor Laninamivir Octanoate versus Oseltamivir for Treatment of Influenza: A Double‐Blind, Randomized, Noninferiority Clinical Trial
- (2010) Akira Watanabe et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations
- (2010) B. E. Davies JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Origins and Evolution of Antibiotic Resistance
- (2010) J. Davies et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Permissive Secondary Mutations Enable the Evolution of Influenza Oseltamivir Resistance
- (2010) J. D. Bloom et al. SCIENCE
- Rapid Emergence of Protease Inhibitor Resistance in Hepatitis C Virus
- (2010) L. Rong et al. Science Translational Medicine
- A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir
- (2010) Yoko Matsuzaki et al. Virology Journal
- Clinical Effectiveness of Oseltamivir and Zanamivir for Treatment of Influenza A Virus Subtype H1N1 with the H274Y Mutation: A Japanese, Multicenter Study of the 2007–2008 and 2008–2009 Influenza Seasons
- (2009) Naoki Kawai et al. CLINICAL INFECTIOUS DISEASES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started